While a cure remains elusive, cancer treatment has seen significant advances in recent years. New innovations include ...

Q4 2025 Earnings Call February 24, 2026 4:30 PM ESTCompany ParticipantsAndrew Guggenhime - President & CFOGrant Pickering ...

The rapid pace of digitalization has created a skills gap, necessitating that staff with traditional chemistry or biology ...

To My Shabbat Soul, I owe you an apology. For years you stood at the corner of my week, softly waving, while I sprinted past ...

Under the morning sun, I climb the steep cobblestone streets of the Albaicín. It’s my second day volunteering in music classes at the local primary school. Upon entering Colegio Público Gomez-Moreno, ...

In a quarter with large style differentials between value and growth, the ClearBridge International Growth ACWI Ex-US ...

In early January, the U.S. Department of Health and Human Services removed the recommendation for universal vaccination ...

From billion-dollar licensing deals to advances in cancer therapies and artificial intelligence, Chinese biotech firms are ...

For the last three years, Bayer has been implementing a new strategy for its oncology development, a strategy that led to multiple approvals, as well as a number of promising new programmes added to ...

U.S. FDA Fast Track designation granted to AKY-11891 for the treatment of adult patients with locally advanced or metastatic urothelial cancer ...

Over the past years, I have closely followed the evolution of the global oncology industry. What I have observed is steady, ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...